Breaking
The Heart Drug Pelacarsen Fails,Shocking Novartis and Cardiologists
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
This story summarizes reporting from The New York Times. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.
Read full story on The New York Times →
Global — Gina Kolata

